Imax (IMAX) will likely keep getting market share as moviegoers around the world seem to "increasingly prefer" the company's screens, Wedbush said in a research note on Thursday.

The investment firm reiterated Imax's outperform rating and $32 price target, and also kept the company on its Best Ideas List.

Wedbush highlighted that the company has "significantly more filmed-for-Imax titles" this year and added its first exclusive for next year, which "should drive incremental market share gains for at least the next two years."

Also, Imax is diversifying its content to improve revenue and is increasing its global footprint with local-language additions, the note said.

"The 2025-2026 global film slates underscore Imax's growing prominence in Hollywood and worldwide as an essential partner for major theatrical releases across genres, languages, and geographies," the investment firm said.

Box office revenue on Imax's global screens rose 8% year on year in Q1 boosted by a record Chinese New Year, the note said.

Imax is slated to reported Q1 results on Wednesday.

Price: 22.31, Change: +0.54, Percent Change: +2.46